These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19840819)

  • 1. Acute SSRI-induced anxiogenic and brain metabolic effects are attenuated 6 months after initial MDMA-induced depletion.
    Andó RD; Adori C; Kirilly E; Molnár E; Kovács GG; Ferrington L; Kelly PA; Bagdy G
    Behav Brain Res; 2010 Mar; 207(2):280-9. PubMed ID: 19840819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET.
    Li IH; Huang WS; Shiue CY; Huang YY; Liu RS; Chyueh SC; Hu SH; Liao MH; Shen LH; Liu JC; Ma KH
    Neuroimage; 2010 Jan; 49(2):1259-70. PubMed ID: 19682588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Kirilly E
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns.
    Adori C; Andó RD; Kovács GG; Bagdy G
    J Comp Neurol; 2006 Jul; 497(2):251-69. PubMed ID: 16705678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDMA-induced serotonergic neurotoxicity enhances aggressiveness in low- but not high-aggressive rats.
    Wallinga AE; ten Voorde AM; de Boer SF; Koolhaas JM; Buwalda B
    Eur J Pharmacol; 2009 Sep; 618(1-3):22-7. PubMed ID: 19616536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the discriminative stimulus effects of S(+)-3,4-methylenedioxymethamphetamine (MDMA) by (+/-)-MDMA neurotoxicity: protection by fluoxetine.
    Virden TB; Baker LE
    Behav Pharmacol; 1999 Mar; 10(2):195-204. PubMed ID: 10780832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions.
    Goñi-Allo B; Ramos M; Herv'as I; Lasheras B; Aguirre N
    J Psychopharmacol; 2006 Mar; 20(2):245-56. PubMed ID: 16510482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery and aging of serotonergic fibers after single and intermittent MDMA treatment in Dark Agouti rat.
    Adori C; Andó RD; Szekeres M; Gutknecht L; Kovács GG; Hunyady L; Lesch KP; Bagdy G
    J Comp Neurol; 2011 Aug; 519(12):2353-78. PubMed ID: 21456018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test.
    Ando RD; Benko A; Ferrington L; Kirilly E; Kelly PA; Bagdy G
    Neuropharmacology; 2006 Jun; 50(7):884-96. PubMed ID: 16472832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
    O'Shea E; Esteban B; Camarero J; Green AR; Colado MI
    Neuropharmacology; 2001; 40(1):65-74. PubMed ID: 11077072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.
    Durkin S; Prendergast A; Harkin A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1894-901. PubMed ID: 18824064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition.
    Gyongyosi N; Balogh B; Kirilly E; Kitka T; Kantor S; Bagdy G
    Brain Res; 2008 Sep; 1231():34-46. PubMed ID: 18638459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical substrates of MDMA reward: effects of the inhibition of serotonin reuptake on the acquisition and reinstatement of MDMA-induced CPP.
    Roger-Sánchez C; Aguilar MA; Manzanedo C; Miñarro J; Rodríguez-Arias M
    Curr Pharm Des; 2013; 19(40):7050-64. PubMed ID: 23574442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low ambient temperature reveals distinct mechanisms for MDMA-induced serotonergic toxicity and astroglial Hsp27 heat shock response in rat brain.
    Adori C; Andó RD; Balázsa T; Soti C; Vas S; Palkovits M; Kovács GG; Bagdy G
    Neurochem Int; 2011 Oct; 59(5):695-705. PubMed ID: 21756954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats.
    Piper BJ; Ali SF; Daniels LG; Meyer JS
    Synapse; 2010 Jun; 64(6):421-31. PubMed ID: 20169574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats.
    Kirilly E; Benko A; Ferrington L; Ando RD; Kelly PA; Bagdy G
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):63-76. PubMed ID: 16060968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic intracerebroventricular 3,4-methylenedioxy-N-methamphetamine (MDMA) or fluoxetine on the active avoidance test in rats with or without exposure to mild chronic stress.
    León LA; Landeira-Fernandez J; Cardenas FP
    Behav Brain Res; 2009 Dec; 205(1):259-64. PubMed ID: 19589359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose of MDMA causes extensive decrement of serotoninergic fibre density without blockage of the fast axonal transport in Dark Agouti rat brain and spinal cord.
    Kovács GG; Andó RD; Adori C; Kirilly E; Benedek A; Palkovits M; Bagdy G
    Neuropathol Appl Neurobiol; 2007 Apr; 33(2):193-203. PubMed ID: 17359360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated BDNF protein level in cortex but not in hippocampus of MDMA-treated Dark Agouti rats: a potential link to the long-term recovery of serotonergic axons.
    Adori C; Andó RD; Ferrington L; Szekeres M; Vas S; Kelly PA; Hunyady L; Bagdy G
    Neurosci Lett; 2010 Jul; 478(2):56-60. PubMed ID: 20435092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.